Clinical Trial Update: Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ibandronate to placebo for osteonecrosis of the femoral head was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Femoral Head

Drugs mentioned

• Ibandronate (ibandronate)

Snippet

Sponsor: Brigitte Jolles, MD | Conditions: Aseptic Hip Necrosis, Hip Necrosis | Phase 3 | Status: TERMINATED